Intuyod K et al., 2019-09: In vitro study reporting that ivermectin inhibits proliferation and colony formation in both gemcitabine-sensitive and gemcitabine-resistant cholangiocarcinoma cell lines.
IVM treatment inhibited cell proliferation and colony formation of both KKU214 and KKU214GemR in a dose- and time-dependent manner.
n/a (PubMed abstract)
Intuyod K et al., 2019-09: In vitro study reporting that ivermectin inhibits proliferation and colony formation in both gemcitabine-sensitive and gemcitabine-resistant cholangiocarcinoma cell lines. Study type: cholangiocarcinoma cell lines (KKU214 gemcitabine-sensitive and KKU214GemR gemcitabine-resistant), in vitro. N: n/a. Country: Thailand (Khon Kaen University). Dose: not stated in the abstract. Funder/COI: not stated in the PubMed record. Comparator: gemcitabine-sensitive vs resistant cells. PARTLY SUPPORTS: the resistant line was MORE sensitive to ivermectin than the sensitive line (paper's own conclusion: 'gemcitabine-resistant KKU214GemR cells are more sensitive to IVM treatment'), which shows activity against a resistant line but does not demonstrate reversal of gemcitabine resistance. Study type: lab.
